Clinical benefit of noninvasive viability studies of patients with severe ischemic left ventricular dysfunction

Clinical Cardiology

Volumn 24, Issue 6, 2001, Pages 428-434

  Soto, Juan R ^a   Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Coronary artery disease; Left ventricular dysfunction; Myocardial perfusion imaging; Myocardial viability; Radionuclide imaging; Technetium 99m; Thallium 201

Indexed keywords

TECHNETIUM 99M; THALLIUM 201;

CELL VIABILITY; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DRUG COST; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; MYOCARDIAL HIBERNATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034989648     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960240603     Document Type: Review

References (55)

1. Epidemiology of heart failure and ventricular dysfunction
2. Imaging in ischemic cardiomyopathy: Therapeutic considerations
3. Reversible ischemic left ventricular dysfunction: Evidence for the "hibernating myocardium."
4. Coronary bypass surgery for chronic angina. A perspective
5. A randomized trial of coronary artery bypass surgery: Survival data
6. Eleven year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina
7. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability
8. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation
9. Myocardial hibernation and stunning: From physiological principles to clinical practice
10. Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral dependent myocardium
11. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: Implications for the pathophysiology of chronic myocardial hibernation
12. Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization
13. Assessment of tissue viability: Clinical demand and problems
14. Chronic myocardial hibernation in humans: From bedside to bench
15. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging
16. Only hibernating myocardium invariably shows early recovery after coronary revascularization
17. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction
18. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability
19. 201thallium imaging for assessing viability of severe asynergic regions
20. Rest-redistribution thallium-201 SPET to detect myocardial viability
21. 99mTc-sestamibi
22. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery
23. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction
24. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization
25. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
26. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction
27. Exercise-rest Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: Direct comparison with Tl-201 reinjection
28. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography
29. Comparative performance of gated perfusion SPECT wall thickening, delayed thallium uptake, and F-18 fluorodeoxyglucose SPECT in detecting myocardial viability
30. 18F]fluorodeoxyglucose single photon emission computed tomography. Can it replace PET and thallium SPECT for the assessment of myocardial viability?
31. Steps forward in the assessment of myocardial viability in left ventricular dysfunction
32. Assessment of viability with fluorine-18 fluorodeoxyglucose positron emission tomography
33. Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction
34. Stress echocardiography with non-exercise techniques: Principles, protocols interpretation, and clinical applications
35. Myocardial viability: Contractile reserve or cell membrane integrity?
36. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction
37. Importance of diagnosing hibernating myocardium: How and in whom?
38. Prognostic utility of myocardial viability assessment
39. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
40. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization
41. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
42. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions
43. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy
44. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease
45. 201Tl single-photon emission CT imaging for determination of myocardial viability: Relationship among viability, mode of therapy, and long-term prognosis
46. Preoperative positron emission tomographic viability assessment and perioperative and post-operative risk in patients with advanced ischemic heart disease
47. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
48. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction
49. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure
50. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography
51. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction
52. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction
53. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function
54. Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction
55. Introduction